Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 70 of 319 for:    FLUTICASONE AND SALMETEROL

Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00404261
Recruitment Status : Completed
First Posted : November 28, 2006
Last Update Posted : October 18, 2012
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : August 2007
Actual Study Completion Date : August 2007
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 September 26, 2017
(Canceled on August 15, 2018)